Advanced Filters
noise

Neoplasms Clinical Trials

A listing of Neoplasms medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 14,180 clinical trials
S Sophia Smith, PhD

Pilot Study of Mindset Moments Among Adolescent and Young Adult Cancer Survivors

The purpose of this study is to evaluate the feasibility and acceptability of the Mindset Moments™ (MM™) program in managing psychological distress and resiliency in adolescent and young adult cancer survivors. Study participation will involve attending 8 weekly, one hour, live online group sessions and completing daily 5 minute activities …

19 - 25 years of age All Phase N/A
L Linda Fleisher, PhD, MPH

mychoiceTM Implementation With Medical Oncology Patients

This is a pragmatic, non-randomized mixed-methods evaluation study designed to evaluate the feasibility and acceptability of delivering the mychoiceTM tool to new Medical Oncology patients as well as to more deeply explore its value to patients in their discussion with their provider about clinical trials as a treatment option over …

18 years of age All Phase N/A
F Fatima Usman

Evidence Development in Cancer Treatment - Real World: PREDiCTrw

This pilot clinical trial aims to assess the real world quality of life and survival of patients treated with therapy that has preliminary evidence of efficacy but uncertainty of the magnitude of clinical benefit or cost effectiveness in subjects with cancer. The goal of this study is to collect real …

18 years of age All Phase N/A
A Anna-Karin Ax, PHD

Medical YOga dUring CANcer Treatment in a Digital or Physical Setting - a PREFERensbased Study

To enhance the implementation of yoga in cancer care, studies that explore patients with cancer preferences for the execution of yoga, effects, and the experience of participating in group yoga sessions online compared to in-person sessions is required. The aim of the YouCanPrefer-study is to explore preferences, expectations, implementation, experiences, …

18 years of age All Phase N/A
N Nancy Lau, PhD

Resilience Mobile App for Teens and Young Adults With Cancer

The goal of this pilot trial is to examine whether a mobile app version of the Promoting Resilience in Stress Management (PRISM) intervention is acceptable, easy to use, and helps improve quality of life and mental health symptoms.

12 - 25 years of age All Phase N/A

A Study of TSN1611 Treating Patients with Advanced Solid Tumors Harboring KRAS G12D Mutation

The study is a first-in-human (FIH), open-label, multi-center phase 1/2 study of TSN1611 in subjects with KRAS G12D mutant advanced solid tumors. This study will consist of a phase 1 dose escalation part and phase 2 dose expansion part.

18 years of age All Phase 1/2
I Ingrid Alexande, MD

A Study of Telemonitoring in Cancer Patients

The goal of this prospective, randomized, unblinded, single-centre, interventional study is to assess the effectiveness of standard of care with Cureety, compared to standard of care alone, to reduce the number of all telephone calls during the first 4 months of oral or intravenous cancer treatment for patients older than …

18 years of age All Phase N/A
M Maria Aagesen, PhD

Evaluating Feasibility of the YATAC Programme

Between 2019 and 2023, the Young Adult Taking Action (YATAC) program was developed to support young adults recovering from cancer. The program is based on three key studies: A review of previous programs designed to help young adult cancer survivors. A study where young adults, their families and friends, and …

18 - 39 years of age All Phase N/A
Q Qian Lu

Health Benefits of Writing Therapy Among Asian American Cancer Survivors

To learn more about participant experience as a Asian American immigrant breast cancer survivor and how writing about participant experiences may affect participant's health.

18 years of age All Phase N/A

TSN084 Treating Patients With Advanced Malignant Tumors

TSN084 is a novel type II kinase inhibitor with demonstrated anti-tumor effects in vitro and in vivo and targets multiple tyrosine kinases, such as c-MET, FLT3, TRK and serine/threonine kinase CDK8/19. This phase 1a/1b study is conducted to assess the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT), to evaluate …

18 years of age All Phase 1

Simplify language using AI